Physician profile
Denise Smith
NPI 1295969947
$25,462.93
in general payments reported to CMS, 2019-2025
25 companies · $2,471 in 2025
The $2,471 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,909 · 2020: $4,637 · 2021: $2,832 · 2022: $8,580 · 2023: $2,341 · 2024: $695 · 2025: $2,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,405 · Travel and Lodging: $2,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,404.60 |
| Travel and Lodging | $2,101.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $8,297.28 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Penumbra, INC. | $4,855.61 | 2019-2025 | Ruby Coil, Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $3,689.89 | 2019-2025 | Viabahn Endoprosthesis With Propaten Bioactive Surface, Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cardiovascular Systems INC. | $1,687.57 | 2019-2021 | |
| Medtronic, INC. | $1,404.94 | 2023-2025 | Ellipsys Vascular Access System, Endurant Iis |
| Silk Road Medical, INC. | $1,201.59 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Boston Scientific Corporation | $1,019.57 | 2019-2025 | Ranger, Eluvia, Enroute .014" Guidewire |
| Inari Medical, INC. | $950.58 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bolton Medical INC | $536.85 | 2020-2021 | |
| Abbott Laboratories | $495.99 | 2024-2025 | Esprit |
| Organogenesis INC. | $305.98 | 2019-2023 | Puraply |
| Bard Peripheral Vascular, INC. | $275.15 | 2020-2025 | Rotarexs 6 F X 135 Cm, Pristine, Lutonix Drug Coated Balloon |
| Medtronic Vascular, INC. | $130.99 | 2019 | |
| Osteocentric Technologies, INC. | $86.92 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Baxter Healthcare | $80.60 | 2024 | Renal - Chronic |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $73.31 | 2020 | |
| Stryker Corporation | $65.52 | 2025 | Clottriever Bold Catheter |
| Lemaitre Vascular, INC. | $57.50 | 2019-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Venclose INC. | $53.61 | 2020 | |
| Cardiva Medical, INC. | $47.62 | 2022-2023 | Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $47.15 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $44.17 | 2020-2022 | |
| Cordis US Corp. | $19.94 | 2023 | Mynx Control |
| Angiodynamics, INC. | $18.57 | 2021 | |
| Convatec INC. | $16.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.